Formic Acid

Formic Acid

SCHEMBL2589657

NC(=O)c1ncccc1Cl.O=CO

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.44
RAB9A P51151 2/20 0.42
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
BLM P54132 1/20 0.39
AGER Q15109 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MKNK1 Q9BUB5 2/20 0.39
MKNK2 Q9HBH9 2/20 0.39
IKBKB O14920 1/20 0.39
PARP1 P09874 1/20 0.39
HTT P42858 1/20 0.38
CTNNB1 P35222 1/20 0.38
WNT3A P56704 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL648916 0.93 SMN1; SMN2 (0.49) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4
SCHEMBL30131336 0.93 SMN1; SMN2 (0.49) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4
SCHEMBL30644588 0.75 ALDH1A1 (0.42) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4
SCHEMBL29229156 0.75 KDM4E (0.45) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4
Formic Acid SCHEMBL28210582 0.75 SMN1; SMN2 (0.48) SMN1; SMN2RAB9AALDH1A1MAPTL3MBTL1
SCHEMBL3412671 0.75 ALDH1A1 (0.46) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4
SCHEMBL29535774 0.75 KDM4E (0.61) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4
SCHEMBL209954 0.75 KDM4E (0.61) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4
SCHEMBL2393997 0.74 TRIM24 (0.50) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4
SCHEMBL365395 0.73 ALDH1A1 (0.45) SMN1; SMN2RAB9AALDH1A1KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011138293-A1 2,5,6,7-TETRAHYDRO-[1,4]OXAZEPIN-3-YLAMINE OR 2,3,6,7-TETRAHYDRO-[1,4]OXAZEPIN-5-YLAMINE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-11-10 WO disclosed